Services

Toxicology

Pharmacology

Animal Model Development

Medical Device Testing

In Vitro Screening

Custom Assay Development

Vivarium Rental

Histology

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Species

Non-human Primates

Dogs

Minipigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Careers

Request a Quote

☰

Bristol-Myers Squibb Release: Modern Family Star Eric Stonestreet Challenges Americans To Support The Cancer Community And Learn About Immuno-Oncology Research Through Ready. Raise. Rise.

  • Post author:
  • Post category:BioPharma

  Life Sciences Jobs   ... Source: BioSpace

Continue ReadingBristol-Myers Squibb Release: Modern Family Star Eric Stonestreet Challenges Americans To Support The Cancer Community And Learn About Immuno-Oncology Research Through Ready. Raise. Rise.

GOP Congressman Lost $16.7 Million in Single Day on This Tanking Biotech Stock

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-ny-republican-rep-chris-collins.jpg" NAME"GOP Congressman Lost $16.7 Million in Single Day on This Tanking Biotech Stock" ALT"GOP Congressman Lost $16.7 Million in Single Day on This Tanking Biotech Stock"June 28, 2017By…

Continue ReadingGOP Congressman Lost $16.7 Million in Single Day on This Tanking Biotech Stock

What Makes Biogen and Bristol-Myers Squibb Such Attractive Takeover Targets

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x430-stock-positive.jpg" NAME"What Makes Biogen and Bristol-Myers Squibb Such Attractive Takeover Targets" ALT"What Makes Biogen and Bristol-Myers Squibb Such Attractive Takeover Targets"June 27, 2017By Mark Terry, BioSpace.com... Source: BioSpace

Continue ReadingWhat Makes Biogen and Bristol-Myers Squibb Such Attractive Takeover Targets